| Clinical significance of prognostic nutritional index (PNI) in malignant melanoma C Mirili, A Yılmaz, S Demirkan, M Bilici, S Basol Tekin International Journal of Clinical Oncology 24, 1301-1310, 2019 | 93 | 2019 |
| The significance of controlling nutritional status (CONUT) score as a novel prognostic parameter in small cell lung cancer A Yılmaz, SB Tekin, M Bilici, H Yılmaz Lung 198, 695-704, 2020 | 46 | 2020 |
| Systemic immune-inflammation index predicting survival outcome in patients with classical Hodgkin lymphoma C Mirili, S Paydas, TK Kapukaya, A Yılmaz Biomarkers in medicine 13 (18), 1565-1575, 2019 | 37 | 2019 |
| A novel predictor in patients with gastrointestinal stromal tumors: Systemic immune-inflammation index (SII). A Yilmaz, C Mirili, M Bilici, SB Tekin Liver 9, 20, 2019 | 34 | 2019 |
| The ratio of hemoglobin to red cell distribution width predicts survival in patients with gastric cancer treated by neoadjuvant FLOT: a retrospective study A Yılmaz, C Mirili, SB Tekin, M Bilici Irish Journal of Medical Science (1971-) 189, 91-102, 2020 | 30 | 2020 |
| The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer A Yılmaz, H Yılmaz, SB Tekin, M Bilici Biomarkers in Medicine 14 (9), 727-738, 2020 | 26 | 2020 |
| Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer H Yılmaz, A Yılmaz, G Demirağ Future Oncology 17 (29), 3853-3864, 2021 | 25 | 2021 |
| Predictive role of neutrophil gelatinase-associated lipocalin in early diagnosis of platin-induced renal injury MM Seker, K Deveci, A Seker, E Sancakdar, A Yilmaz, AK Turesin, ... Asian Pacific Journal of Cancer Prevention 16 (2), 407-410, 2015 | 22 | 2015 |
| Colorectal cancer in Lynch syndrome associated with PMS2 and MSH6 mutations A Yılmaz, C Mirili, M Bilici, SB Tekin International journal of colorectal disease 35, 351-353, 2020 | 18 | 2020 |
| Possible atezolizumab-associated acute kidney injury and immune thrombocytopenia A Yılmaz, C Mirili, M Bilici, SB Tekin Journal of Oncology Pharmacy Practice 26 (7), 1791-1794, 2020 | 14 | 2020 |
| Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis C Huzmeli, F Candan, G Bagci, D Alaygut, A Yilmaz, A Gedikli, B Bagci, ... Clinical rheumatology 36, 2589-2594, 2017 | 12 | 2017 |
| A novel prognostic biomarker for cutaneous malignant melanoma: red cell distribution width (RDW) to lymphocyte ratio Z Hannarici, A Yilmaz, ME Buyukbayram, SB Tekin, M Bilici Melanoma research 31 (6), 566-574, 2021 | 10 | 2021 |
| The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib A Yılmaz, M Şimşek, Z Hannarici, ME Büyükbayram, M Bilici, SB Tekin Future Oncology 17 (33), 4545-4559, 2021 | 9 | 2021 |
| Predictive significance of Ki-67 and platelet lymphocyte ratio in patients with gastric cancer receiving neoadjuvant FLOT chemotherapy H Yilmaz, G Demirağ, Y Süllü, A Yilmaz JCPSP-Journal of the College of Physicians and Surgeons Pakistan 31 (5), 2021 | 5 | 2021 |
| The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer Z Hannarici, A Yılmaz, ME Buyukbayram, A Turhan, AA Çağlar, M Bilici, ... Future Oncology 19 (4), 315-325, 2023 | 3 | 2023 |
| Irritable Bowel Syndrome in Dialysis Patients and Symptom Check List Revised (SCL 90-R) Screening A Yılmaz, P Gökçen, H Yılmaz, C Hüzmeli, A Yılmaz The Eurasian Journal of Medicine 53 (3), 220, 2021 | 3 | 2021 |
| Clinical significance of inflammatory indexes in patients with epithelial ovarian cancer A Yılmaz, S Tekin, M Bilici, H Yılmaz Acta Oncol Tur 53 (3), 402-9, 2020 | 2 | 2020 |
| Long-Term Follow-Up Outcomes of Cervical Cancer Patients: A Single Center Experience from the East Anatolian Region of Turkey C Mirili, A Yılmaz, M Bilici, SB Tekin Dicle Tıp Dergisi 46 (4), 857-865, 2019 | 2 | 2019 |
| Prognostic significance of dynamic inflammatory indexes in cases renal cell cancer treated by tyrosine kinase inhibitor (TKI) C Mirili, S Paydas, A Yılmaz, A Oğul, M Buyuksimsek, AE Yetisir, ... Acta Oncologica Turcica 52 (3), 372-378, 2019 | 1 | 2019 |
| Non-metastatik mide kanserli olgularda prognostik faktörler T Kaçan, NA Babacan, S Kılıçkap, M Şeker, B Yücel, T Uncu, A Yılmaz Cumhuriyet Medical Journal 35 (3), 326-331, 2013 | 1 | 2013 |
